Skip to content

Utah Medical Products UTMD Estimated litigation liability

Estimated litigation liability at other companies

TFX
TeleflexTFX
Baxter International logo
Baxter InternationalBAX

Other financials

Income statement

See full
Revenue$8.7M-10.2%
Gross profit$5.3M-4.6%
Operating income$2.6M-18.6%
Net income$2.6M-14.4%
EPS (diluted)$0.82-10.9%

Balance sheet

See full
Cash & equivalents$87.4M+4.9%
Total debt$210.0K
Total equity$120.4M+2.8%
Total assets$124.4M+1.5%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%
Free cash flow$3.0M-30.4%

Valuation

See full
Market cap$219.63M+26.4%
Enterprise value$132.44M+42.5%
P/E20.3×+6.4×
P/S5.9×+1.4×

Profitability

See full
Gross margin57.9%-0.4pp
Operating margin28.8%-3.9pp
Net margin28.9%-4.1pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Return on equity9.1%-1.4pp
Debt / equity
Current ratio28.6×+6.3×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:LitigationReserve.

The official record: Utah Medical Products’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's estimated litigation liability.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's estimated litigation liability?
Utah Medical Products (UTMD) reported estimated litigation liability of $68K in Q4 2025.
How has Utah Medical Products's estimated litigation liability changed year-over-year?
Utah Medical Products's estimated litigation liability decreased by 38.7% year-over-year, from $111K to $68K.
What is the long-term trend for Utah Medical Products's estimated litigation liability?
Over 5 years (2020 to 2025), Utah Medical Products's estimated litigation liability has grown at a -9.7% compound annual growth rate (CAGR), from $113K to $68K.